July 18, 2022

Bernadett S et al. European Urology, 2022

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder

Download Publication

You might also be interested by

Brochures

Immunohistochemistry (IHC) Biomarker List

April 17, 2023

Histopathology

More info

Videos

Our Histopathology Laboratories

November 22, 2022

Histopathology

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info